메뉴 건너뛰기




Volumn 10, Issue 17, 2004, Pages 5769-5776

Estrogen receptor β (ERβ) level but not its ERβcx variant helps to predict tamoxifen resistance in breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA CX; KI 67 ANTIGEN; TAMOXIFEN; UNCLASSIFIED DRUG;

EID: 4444254432     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0389     Document Type: Article
Times cited : (142)

References (36)
  • 1
    • 0025933431 scopus 로고
    • Antiestrogen resistance: Mechanisms by which cancer cells undermine the effectiveness of endocrine therapy
    • Katzenellenbogen BS. Antiestrogen resistance: mechanisms by which cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst (Bethesda) 1991;83:1433-5.
    • (1991) J Natl Cancer Inst (Bethesda) , vol.83 , pp. 1433-1435
    • Katzenellenbogen, B.S.1
  • 2
    • 0032569831 scopus 로고    scopus 로고
    • Tamoxifen in the treatment of breast cancer
    • Osborne C. Tamoxifen in the treatment of breast cancer. N Engl J Med 1998;339:1609-18.
    • (1998) N Engl J Med , vol.339 , pp. 1609-1618
    • Osborne, C.1
  • 3
    • 0036488531 scopus 로고    scopus 로고
    • Endocrine-responsive breast cancer and strategies for combatting resistance
    • Ali S, Coombs CR. Endocrine-responsive breast cancer and strategies for combatting resistance. Nat Rev Cancer 2002;2:101-12.
    • (2002) Nat Rev Cancer , vol.2 , pp. 101-112
    • Ali, S.1    Coombs, C.R.2
  • 4
    • 0021133540 scopus 로고
    • Effects of antiestrogens on the estrogen-regulated pS2 RNA, and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen resistant sublines
    • Westley B, May FEB, Brown AMC, et al. Effects of antiestrogens on the estrogen-regulated pS2 RNA, and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen resistant sublines. J Biol Chem 1984;259:10030-5.
    • (1984) J Biol Chem , vol.259 , pp. 10030-10035
    • Westley, B.1    May, F.E.B.2    Brown, A.M.C.3
  • 5
    • 0019797751 scopus 로고
    • Isolation and characterization of tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells
    • Nawata H, Bronzert D, Lippman ME. Isolation and characterization of tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells. J Biol Chem 1981;256:5016-21.
    • (1981) J Biol Chem , vol.256 , pp. 5016-5021
    • Nawata, H.1    Bronzert, D.2    Lippman, M.E.3
  • 6
    • 0030016280 scopus 로고    scopus 로고
    • Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-estrogen ICI 182780 in women with advanced breast cancer
    • Howell A, DeFriend DJ, Robertson JF, et al. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-estrogen ICI 182780 in women with advanced breast cancer. Br J Cancer 1996;74:300-8.
    • (1996) Br J Cancer , vol.74 , pp. 300-308
    • Howell, A.1    DeFriend, D.J.2    Robertson, J.F.3
  • 7
    • 0020003085 scopus 로고
    • Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth
    • Coezy E, Borgna JL, Rochefort H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982;42:317-23.
    • (1982) Cancer Res , vol.42 , pp. 317-323
    • Coezy, E.1    Borgna, J.L.2    Rochefort, H.3
  • 8
    • 0021235629 scopus 로고
    • The antiproliferative effect of tamoxifen in breast cancer cells: Mediation by the estrogen receptor
    • Bardon S, Vignon F, Derocq D, Rochefort H. The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor. Mol Cell Endocrinol 1984;35:89-96.
    • (1984) Mol Cell Endocrinol , vol.35 , pp. 89-96
    • Bardon, S.1    Vignon, F.2    Derocq, D.3    Rochefort, H.4
  • 9
    • 0026557343 scopus 로고
    • Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 Randomised trials involving 31,000 recurrences and 24,000 deaths among 75000 women
    • Early Breast Cancer Trialists' Collaborative Group
    • Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet 1992;339:1-15, 71-85.
    • (1992) Lancet , vol.339 , pp. 1-15
  • 10
    • 0016755280 scopus 로고
    • Current status of estrogen receptors in human breast cancer
    • Mc Guire WL. Current status of estrogen receptors in human breast cancer. Cancer (Phila) 1975;36:638-44.
    • (1975) Cancer (Phila) , vol.36 , pp. 638-644
    • Mc Guire, W.L.1
  • 11
    • 0033386954 scopus 로고    scopus 로고
    • Estrogen receptor β - A new dimension in estrogen mechanism of action
    • Gustafsson JA. Estrogen receptor β-a new dimension in estrogen mechanism of action. J Endocrinol 1999;163:379-83.
    • (1999) J Endocrinol , vol.163 , pp. 379-383
    • Gustafsson, J.A.1
  • 12
    • 0019411776 scopus 로고
    • Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues
    • Borgna JL, Rochefort H. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. J Biol Chem 1981;256:859-68.
    • (1981) J Biol Chem , vol.256 , pp. 859-868
    • Borgna, J.L.1    Rochefort, H.2
  • 13
    • 0031039888 scopus 로고    scopus 로고
    • Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β
    • Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocrinology 1997;138:863-70.
    • (1997) Endocrinology , vol.138 , pp. 863-870
    • Kuiper, G.G.J.M.1    Carlsson, B.2    Grandien, K.3
  • 16
    • 0034641862 scopus 로고    scopus 로고
    • Estrogen receptor β acts as a dominant regulator of estrogen signaling
    • Pettersson K, Delaunay F, Gustafsson JA. Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 2000;19: 4970-8.
    • (2000) Oncogene , vol.19 , pp. 4970-4978
    • Pettersson, K.1    Delaunay, F.2    Gustafsson, J.A.3
  • 17
    • 0030801841 scopus 로고    scopus 로고
    • Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites
    • Paech K, Webb P, Kuiper GGJM, et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science (Wash DC) 1997;277:1508-10.
    • (1997) Science (Wash DC) , vol.277 , pp. 1508-1510
    • Paech, K.1    Webb, P.2    Kuiper, G.G.J.M.3
  • 18
    • 0025062215 scopus 로고
    • Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context-dependent agonistic activity of the antiestrogen 4-hydroxytamoxifen
    • Berry M, Metzger D, Chambon P. Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context-dependent agonistic activity of the antiestrogen 4-hydroxytamoxifen. EMBO. J 1990;9:2811-8.
    • (1990) EMBO J , vol.9 , pp. 2811-2818
    • Berry, M.1    Metzger, D.2    Chambon, P.3
  • 19
    • 0033856986 scopus 로고    scopus 로고
    • Functional differences between the amino-terminal domains of estrogen receptors α and β
    • Delaunay F, Pettersson K, Tujague M, Gustafsson JA. Functional differences between the amino-terminal domains of estrogen receptors α and β. Mol Pharmacol 2000;58:584-90.
    • (2000) Mol Pharmacol , vol.58 , pp. 584-590
    • Delaunay, F.1    Pettersson, K.2    Tujague, M.3    Gustafsson, J.A.4
  • 20
    • 0036533986 scopus 로고    scopus 로고
    • Breast cancer consensus meetings: Vive la difference
    • Davidson NE, Levine M. Breast cancer consensus meetings: vive la difference. J Clin Oncol 2002;20:1719-20.
    • (2002) J Clin Oncol , vol.20 , pp. 1719-1720
    • Davidson, N.E.1    Levine, M.2
  • 21
    • 70449185514 scopus 로고
    • Histological grading and prognosis in breast cancer
    • Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-77.
    • (1957) Br J Cancer , vol.11 , pp. 359-377
    • Bloom, H.J.G.1    Richardson, W.W.2
  • 22
    • 0001271962 scopus 로고
    • Grading of invasive carcinoma of the breast
    • Page D, Andreson T, editors. Edinburgh: Churchill Livingstone
    • Elston, C. Grading of invasive carcinoma of the breast. In: Page D, Andreson T, editors. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone; 1987. p. 300-11.
    • (1987) Diagnostic Histopathology of the Breast , pp. 300-311
    • Elston, C.1
  • 23
    • 0035866760 scopus 로고    scopus 로고
    • Decreased expression of estrogen receptor β protein in prolliferative preinvasive mammary tumors
    • Roger P, Esslimani Sahla M, Makela S, Gustafsson JA, Baldet P, Rochefort H. Decreased expression of estrogen receptor β protein in prolliferative preinvasive mammary tumors. Cancer Res 2001;61:2537-41.
    • (2001) Cancer Res , vol.61 , pp. 2537-2541
    • Roger, P.1    Esslimani Sahla, M.2    Makela, S.3    Gustafsson, J.A.4    Baldet, P.5    Rochefort, H.6
  • 25
    • 33544471177 scopus 로고
    • Applied logistic regression
    • John Wiley & Sons, editors. New York
    • Hosmer DW and Lemeshow SL. Applied logistic regression. In: John Wiley & Sons, editors. Wiley Interscience. New York; 1989.
    • (1989) Wiley Interscience
    • Hosmer, D.W.1    Lemeshow, S.L.2
  • 27
    • 0035122520 scopus 로고    scopus 로고
    • Estrogen receptor β expression in invasive breast cancer
    • Mann S, Laucirica R, Carlson N, et al. Estrogen receptor β expression in invasive breast cancer. Hum Pathol 2001;32:113-8.
    • (2001) Hum Pathol , vol.32 , pp. 113-118
    • Mann, S.1    Laucirica, R.2    Carlson, N.3
  • 28
    • 0037011662 scopus 로고    scopus 로고
    • Relationship of coregulator and estrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
    • Murphy LC, Leygue E, Niu Y, Snell L, Ho SM, Watson PH. Relationship of coregulator and estrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer. Br J cancer 2002;87:1411-6.
    • (2002) Br J Cancer , vol.87 , pp. 1411-1416
    • Murphy, L.C.1    Leygue, E.2    Niu, Y.3    Snell, L.4    Ho, S.M.5    Watson, P.H.6
  • 29
    • 0033231027 scopus 로고    scopus 로고
    • Increased expression of receptor β mRNA in tamoxifen-resistant breast cancer patients
    • Speirs V, Malone C, Walton DS, Kerin MJ, Atkin SL. Increased expression of receptor β mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 1999;59:5421-4.
    • (1999) Cancer Res , vol.59 , pp. 5421-5424
    • Speirs, V.1    Malone, C.2    Walton, D.S.3    Kerin, M.J.4    Atkin, S.L.5
  • 30
    • 4444293615 scopus 로고    scopus 로고
    • Effects on breast cancer: Clinical aspects
    • Lindsay R, Dempster DW, Jordan VC, editors. Philadelphia: Lippincott-Raven Publishers
    • Pritchard K. Effects on breast cancer: clinical aspects. In: Lindsay R, Dempster DW, Jordan VC, editors. Estrogens and antiestrogens. Philadelphia: Lippincott-Raven Publishers; 1997. p. 175-210.
    • (1997) Estrogens and Antiestrogens , pp. 175-210
    • Pritchard, K.1
  • 31
    • 0036735297 scopus 로고    scopus 로고
    • Expression of estrogen receptor (ER) βcx protein in ERα positive breast cancer. Specific correlation with progesterone receptor
    • Saji S, Omoto Y, Shimizu C, et al. Expression of estrogen receptor (ER) βcx protein in ERα positive breast cancer. Specific correlation with progesterone receptor. Cancer Res 2002;62:4849-53.
    • (2002) Cancer Res , vol.62 , pp. 4849-4853
    • Saji, S.1    Omoto, Y.2    Shimizu, C.3
  • 32
    • 0141995803 scopus 로고    scopus 로고
    • Reduced expression of estrogen receptor β in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model
    • Skrilis GP, Munot K, Bell SM, et al. Reduced expression of estrogen receptor β in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model. J Pathol 2003; 201:213-20.
    • (2003) J Pathol , vol.201 , pp. 213-220
    • Skrilis, G.P.1    Munot, K.2    Bell, S.M.3
  • 33
    • 0037506015 scopus 로고    scopus 로고
    • Estrogen receptor β protein in human breast cancer: Correlation with clinical tumor parameters
    • Fuqua SAW, Schiff R, Parra I, et al. Estrogen receptor β protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res 2003;63:2434-9.
    • (2003) Cancer Res , vol.63 , pp. 2434-2439
    • Fuqua, S.A.W.1    Schiff, R.2    Parra, I.3
  • 34
    • 0037420192 scopus 로고    scopus 로고
    • Role of the estrogen receptor coactivator AIB-1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
    • Osbome CK, Bardou V, Hopp TA, et al. Role of the estrogen receptor coactivator AIB-1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst (Bethesda) 2003;95:353-61.
    • (2003) J Natl Cancer Inst (Bethesda) , vol.95 , pp. 353-361
    • Osbome, C.K.1    Bardou, V.2    Hopp, T.A.3
  • 35
    • 0037192501 scopus 로고    scopus 로고
    • Molecular determinants for the tissue specificity of SERMs
    • Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science (Wash DC) 2002;295:2465-8.
    • (2002) Science (Wash DC) , vol.295 , pp. 2465-2468
    • Shang, Y.1    Brown, M.2
  • 36
    • 0034664769 scopus 로고    scopus 로고
    • Combinatorial roles of the nuclear receptor corepressor in transcription and development
    • Jepsen K, Hermanson O, Onami TM, et al. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 2000;102:753-63.
    • (2000) Cell , vol.102 , pp. 753-763
    • Jepsen, K.1    Hermanson, O.2    Onami, T.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.